医学
指南
重症监护医学
梅德林
病理
政治学
法学
作者
Rieke Alten,Max Mischkewitz
标识
DOI:10.1038/s41584-021-00667-2
摘要
The 2021 ACR guideline for the treatment of rheumatoid arthritis provides an update on several important topics, including the use of targeted synthetic DMARDs (tsDMARDs). But how does the new guideline compare to EULAR recommendations, and is the growing importance of tsDMARDs adequately accounted for?
科研通智能强力驱动
Strongly Powered by AbleSci AI